Study

Clinical and urodynamic effects of norfenefrine in women with stress incontinence. – Cost Effective Supplements

Clinical and urodynamic effects of norfenefrine in women with stress incontinence.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/6150569


Conclusion of this study

20 women with stress incontinence were treated with an alpha-adrenoceptor stimulating agent norfenefrine (Nevadral Retard) for 3 months. The mean dose administered was 60 mg given in slow-release tablets. Significant beneficial effect on the symptom and the 'sign' of stress incontinence was found as well as a significant increase in the maximum urethral closure pressure. 7 patients (35%) became subjectively and objectively continent. Only minor side effects were observed during treatment.


Supplements analyzed in this study

Octopamine

Health conditions analyzed in this study

Urinary Incontinence


Slightly Positive
Octopamine


Functions related to this study

Overall health


Slightly Positive
Octopamine


Body systems related to this study


Urinary System
Scroll to top